Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts-Reference-Cited by-同舟云学术

Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Published:2019-05-29 Issue:17 Volume:79 Page:4539-4550
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Mer Arvind S.,Ba-Alawi Wail,Smirnov Petr^ORCID,Wang Yi X.,Brew Ben,Ortmann Janosch^ORCID,Tsao Ming-Sound^ORCID,Cescon David W.,Goldenberg Anna,Haibe-Kains Benjamin^ORCID

Funder

Canadian Cancer SocietyCanadian Cancer Society (Société canadienne du cancer)

Ontario Institute for Cancer ResearchOntario Institute for Cancer Research (OICR)

Canadian Breast Cancer FoundationCanadian Breast Cancer Foundation (CBCF)

Terry Fox Research InstituteTerry Fox Research Institute (TFRI)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine;Life;2024-09-10

2. Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts;Journal of Translational Medicine;2024-08-05

3. Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality;2024-07-22

4. Capturing heterogeneity in PDX models: representation matters;Nature Communications;2024-05-31

5. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models;Nature Communications;2024-05-31